latest news releases from the newsroom
MorphoSys AG: AbD Serotec Receives Large Research Antibody Order From Proteomics Specialist Proteomika
MARTINSRIED, Germany, March 5, 2008 (PRIME NEWSWIRE) -- MorphoSys AG (FSE:MOR) (Prime Standard Segment:TecDAX) today announced that its AbD Serotec business unit has received a multiple research antibody order from Proteomika SL, a Spanish biotechnology company specializing in biomarker discovery. Proteomika has ordered novel, HuCAL-based, research antibodies against a broad range of target molecules in addition to the production of antigen material at AbD Serotec. AbD Serotec will apply MorphoSys's HuCAL GOLD antibody technology and the proprietary Antigen Expression System AgX(tm). The order ranks Proteomika among the largest customers for custom monoclonals services provided by AbD Serotec. Financial details of the agreement were not disclosed.
Nobel Biocare Strengthens Executive Management
ZURICH, Switzerland, March 5, 2008 (PRIME NEWSWIRE) -- Nobel Biocare announced today the appointment of Dr. Dirk Kirsten (39) as new Chief Financial Officer and member of the Executive Committee. He will assume his new role in the first half 2008. Kirsten, a Swiss/German citizen, will join Nobel Biocare from Syngenta where he has been Group Treasurer since 2005. Prior to that he was with Roche as Head of Group Funding & Capital Markets, Deutsche Bank as Director of Corporate Finance and PricewaterhouseCoopers. Dirk Kirsten has a broad background in finance and a proven track record in senior finance positions at large publicly listed companies. He holds a masters degree in economy from the University of Cologne and the London Business School, as well as a PhD in banking/management from the University of Cologne. Dirk Kirsten will replace Dr. Thomas Bogli, who has decided to pursue other opportunities outside the company.
Kahn Swick & Foti, LLC
Investor Alert: KGS Urges Investors Who Have Lost More Than $100,000 in Municipal Mortgage & Equity, LLC Shares to Inquire About Lead Plaintiff Position in Securities Class Action Lawsuit -- MMAB
NEW ORLEANS, March 4, 2008 (PRIME NEWSWIRE) -- Kahn Gauthier Swick, LLC ("KGS"), one of the law firms that has filed a class action lawsuit against Municipal Mortgage & Equity, LLC ("MMA" or the "Company") (Pink Sheets:MMAB) (formerly (NYSE:MMA)) in the United States District Court for the District of Maryland, on behalf of shareholders who purchased the common stock of the Company between May 3, 2004 and January 29, 2008, inclusive (the "Class Period"), urges investors who have lost more than $100,000 to inquire about applying for the lead plaintiff position in the case. No class has yet been certified in this action.